The translational landscape of SARS-CoV-2-infected cells reveals suppression of innate immune genes

Maritza Puray-Chavez, Washington University School of Medicine in St. Louis
Nakyung Lee, Washington University School of Medicine in St. Louis
Kasyap Tenneti, Washington University School of Medicine in St. Louis
Yiqing Wang, Washington University School of Medicine in St. Louis
Hung R Vuong, Washington University School of Medicine in St. Louis
Yating Liu, Washington University School of Medicine in St. Louis
Amjad Horani, Washington University School of Medicine in St. Louis
Tao Huang, Washington University School of Medicine in St. Louis
Sean P Gunsten, Washington University School of Medicine in St. Louis
James B Case, Washington University School of Medicine in St. Louis
Wei Yang, Washington University School of Medicine in St. Louis
Michael S Diamond, Washington University School of Medicine in St. Louis
Steven L Brody, Washington University School of Medicine in St. Louis
Joseph Dougherty, Washington University School of Medicine in St. Louis
Sebla B Kutluay, Washington University School of Medicine in St. Louis

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) utilizes a number of strategies to modulate viral and host mRNA translation. Here, we used ribosome profiling in SARS-CoV-2-infected model cell lines and primary airway cells grown at an air-liquid interface to gain a deeper understanding of the translationally regulated events in response to virus replication. We found that SARS-CoV-2 mRNAs dominate the cellular mRNA pool but are not more efficiently translated than cellular mRNAs. SARS-CoV-2 utilized a highly efficient ribosomal frameshifting strategy despite notable accumulation of ribosomes within the slippery sequence on the frameshifting element. In a highly permissive cell line model, although SARS-CoV-2 infection induced the transcriptional upregulation of numerous chemokine, cytokine, and interferon-stimulated genes, many of these mRNAs were not translated efficiently. The impact of SARS-CoV-2 on host mRNA translation was more subtle in primary cells, with marked transcriptional and translational upregulation of inflammatory and innate immune responses and downregulation of processes involved in ciliated cell function. Together, these data reveal the key role of mRNA translation in SARS-CoV-2 replication and highlight unique mechanisms for therapeutic development.